Cytosorbents Corporation (CTSO)
USD 1.0
(1.18%)
USD 1.0
(1.18%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.68 Million USD | 6.33% |
| 2022 | 3.46 Million USD | -27.38% |
| 2021 | 4.76 Million USD | 78.23% |
| 2020 | 2.67 Million USD | 26.49% |
| 2019 | 2.11 Million USD | 153.74% |
| 2018 | 833.13 Thousand USD | 4.71% |
| 2017 | 795.65 Thousand USD | -4.59% |
| 2016 | 833.97 Thousand USD | -29.96% |
| 2015 | 1.19 Million USD | 121.32% |
| 2014 | 538 Thousand USD | 119.05% |
| 2013 | 245.6 Thousand USD | -64.01% |
| 2012 | 682.37 Thousand USD | 58.31% |
| 2011 | 431.02 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.73 Million USD | 1.59% |
| 2024 Q2 | 4.31 Million USD | 15.46% |
| 2023 FY | 3.68 Million USD | 6.33% |
| 2023 Q4 | 3.68 Million USD | 23.62% |
| 2023 Q3 | 2.97 Million USD | 45.5% |
| 2023 Q2 | 2.04 Million USD | 18.54% |
| 2023 Q1 | 1.72 Million USD | -50.14% |
| 2022 Q4 | 3.46 Million USD | -2.26% |
| 2022 Q1 | 5.44 Million USD | 14.26% |
| 2022 FY | 3.46 Million USD | -27.38% |
| 2022 Q2 | 4.98 Million USD | -8.54% |
| 2022 Q3 | 3.54 Million USD | -28.89% |
| 2021 Q1 | 3.1 Million USD | 16.25% |
| 2021 FY | 4.76 Million USD | 78.23% |
| 2021 Q2 | 3.68 Million USD | 18.68% |
| 2021 Q3 | 4.52 Million USD | 22.73% |
| 2021 Q4 | 4.76 Million USD | 5.27% |
| 2020 Q3 | 2.02 Million USD | 1.91% |
| 2020 FY | 2.67 Million USD | 26.49% |
| 2020 Q1 | 1.96 Million USD | -6.95% |
| 2020 Q2 | 1.98 Million USD | 1.02% |
| 2020 Q4 | 2.67 Million USD | 32.04% |
| 2019 Q4 | 2.11 Million USD | 19.56% |
| 2019 Q3 | 1.76 Million USD | 20.85% |
| 2019 Q2 | 1.46 Million USD | 20.55% |
| 2019 Q1 | 1.21 Million USD | 45.67% |
| 2019 FY | 2.11 Million USD | 153.74% |
| 2018 Q1 | 680.18 Thousand USD | -14.51% |
| 2018 Q3 | 779.42 Thousand USD | 1.32% |
| 2018 Q4 | 833.13 Thousand USD | 6.89% |
| 2018 FY | 833.13 Thousand USD | 4.71% |
| 2018 Q2 | 769.24 Thousand USD | 13.09% |
| 2017 Q4 | 795.65 Thousand USD | -26.96% |
| 2017 Q2 | 889.73 Thousand USD | 3.73% |
| 2017 FY | 795.65 Thousand USD | -4.59% |
| 2017 Q1 | 857.78 Thousand USD | 2.85% |
| 2017 Q3 | 1.08 Million USD | 22.43% |
| 2016 Q4 | 833.97 Thousand USD | -20.7% |
| 2016 FY | 833.97 Thousand USD | -29.96% |
| 2016 Q3 | 1.05 Million USD | 0.36% |
| 2016 Q2 | 1.04 Million USD | -1.11% |
| 2016 Q1 | 1.05 Million USD | -11.01% |
| 2015 Q4 | 1.19 Million USD | -10.96% |
| 2015 FY | 1.19 Million USD | 121.32% |
| 2015 Q1 | 702.92 Thousand USD | 30.76% |
| 2015 Q2 | 1.05 Million USD | 50.79% |
| 2015 Q3 | 1.33 Million USD | 26.16% |
| 2014 Q3 | 387.07 Thousand USD | 27.46% |
| 2014 FY | 538 Thousand USD | 119.05% |
| 2014 Q4 | 537.56 Thousand USD | 38.88% |
| 2014 Q1 | 146.52 Thousand USD | -40.34% |
| 2014 Q2 | 303.68 Thousand USD | 107.26% |
| 2013 Q1 | 555.26 Thousand USD | -18.63% |
| 2013 FY | 245.6 Thousand USD | -64.01% |
| 2013 Q2 | 476.55 Thousand USD | -14.18% |
| 2013 Q3 | 362.54 Thousand USD | -23.92% |
| 2013 Q4 | 245.6 Thousand USD | -32.25% |
| 2012 FY | 682.37 Thousand USD | 58.31% |
| 2012 Q1 | 468.56 Thousand USD | 8.71% |
| 2012 Q4 | 682.37 Thousand USD | 9.04% |
| 2012 Q3 | 625.77 Thousand USD | 16.91% |
| 2012 Q2 | 535.25 Thousand USD | 14.23% |
| 2011 Q4 | 431.02 Thousand USD | 131.31% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | 186.33 Thousand USD | 0.0% |
| 2011 FY | 431.02 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | -1733.00 USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 100.0% |
| 2004 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -11.182% |
| BrainsWay Ltd. | 3.71 Million USD | 0.992% |
| Cerus Corporation | 39.86 Million USD | 90.769% |
| Envoy Medical, Inc. | 1.4 Million USD | -162.117% |
| electroCore, Inc. | 2.16 Million USD | -70.376% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -705.28% |
| IceCure Medical Ltd | 2.27 Million USD | -61.764% |
| Inogen, Inc. | 21.84 Million USD | 83.15% |
| OrthoPediatrics Corp. | 105.85 Million USD | 96.523% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -1223.787% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -368012800.0% |
| MaxCyte, Inc. | 12.22 Million USD | 69.907% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -113.132% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -2252.723% |
| Orthofix Medical Inc. | 222.16 Million USD | 98.344% |
| PAVmed Inc | 1.01 Million USD | -261.862% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 81.563% |
| RxSight, Inc. | 17.42 Million USD | 78.875% |
| Sight Sciences, Inc. | 7.84 Million USD | 53.113% |
| SI-BONE, Inc. | 20.24 Million USD | 81.826% |
| TELA Bio, Inc. | 13.16 Million USD | 72.04% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 87.416% |
| Vivos Therapeutics, Inc. | 1.00 USD | -368012800.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 13.975% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -1500.056% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -56.202% |
| CVRx, Inc. | 10.98 Million USD | 66.492% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -843.439% |
| Bioventus Inc. | 91.33 Million USD | 95.971% |
| Venus Concept Inc. | 28.67 Million USD | 87.167% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -44.602% |
| LivaNova PLC | 147.88 Million USD | 97.512% |
| 908 Devices Inc. | 14.93 Million USD | 75.364% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 97.311% |
| Nemaura Medical Inc. | 1.75 Million USD | -109.712% |
| NeuroPace, Inc. | 11.21 Million USD | 67.183% |
| LENSAR, Inc. | 15.68 Million USD | 76.543% |
| Apyx Medical Corporation | 9.92 Million USD | 62.913% |
| Cutera, Inc. | 72.1 Million USD | 94.896% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -37.678% |
| BioSig Technologies, Inc. | -103 Thousand USD | 3672.941% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 92.066% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 53.481% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.055% |
| Axonics, Inc. | 79.94 Million USD | 95.396% |
| Outset Medical, Inc. | 49.21 Million USD | 92.522% |
| IRIDEX Corporation | 9.9 Million USD | 62.849% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 90.743% |
| IRadimed Corporation | 12.82 Million USD | 71.297% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -386.79% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -1291.316% |
| Telesis Bio, Inc. | 4.02 Million USD | 8.568% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 20.072% |
| Varex Imaging Corporation | 277.5 Million USD | 98.674% |
| Quipt Home Medical Corp. | 18.32 Million USD | 79.918% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 78.02% |
| Dynatronics Corporation | 5.59 Million USD | 34.213% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 1.627% |
| Semler Scientific, Inc. | 445 Thousand USD | -726.995% |
| InMode Ltd. | 45.09 Million USD | 91.839% |
| Bruker Corporation | 968.3 Million USD | 99.62% |
| DexCom, Inc. | 559.6 Million USD | 99.342% |
| Align Technology, Inc. | 296.9 Million USD | 98.76% |
| Viveve Medical, Inc. | 1.47 Million USD | -150.009% |
| ZimVie Inc. | 79.6 Million USD | 95.377% |
| Movano Inc. | 1.51 Million USD | -143.234% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 93.955% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -2252.723% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 97.67% |
| Profound Medical Corp. | 6.95 Million USD | 47.073% |
| Insulet Corporation | 402.6 Million USD | 99.086% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 75.2% |
| iCAD, Inc. | 917 Thousand USD | -301.323% |
| Nuwellis, Inc. | 1.99 Million USD | -84.283% |
| Biotricity, Inc. | 1.87 Million USD | -95.814% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 73.663% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -74.745% |
| PAVmed Inc. | 1.01 Million USD | -261.862% |
| BIOLASE, Inc. | 11.43 Million USD | 67.811% |
| Beyond Air, Inc. | 2.12 Million USD | -73.02% |
| FONAR Corporation | 2.71 Million USD | -35.526% |
| AxoGen, Inc. | 23.02 Million USD | 84.013% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 83.663% |
| Inari Medical, Inc. | 42.9 Million USD | 91.422% |
| UFP Technologies, Inc. | 70.19 Million USD | 94.757% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -484.91% |
| Tenon Medical, Inc. | 554 Thousand USD | -564.283% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -121.065% |
| AdaptHealth Corp. | 113.64 Million USD | 96.762% |
| Sintx Technologies, Inc. | 888 Thousand USD | -314.429% |
| NanoVibronix, Inc. | 2.73 Million USD | -34.705% |
| Quanterix Corporation | 22.36 Million USD | 83.545% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 75.213% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 93.507% |
| TransMedics Group, Inc. | 44.23 Million USD | 91.681% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 34.9% |
| NeuroMetrix, Inc. | 1.55 Million USD | -135.992% |
| Hyperfine, Inc. | 6.58 Million USD | 44.088% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 95.396% |
| Biomerica, Inc. | 2.37 Million USD | -54.888% |
| Bone Biologics Corporation | -328.84 Thousand USD | 1219.111% |
| AVITA Medical, Inc. | 3.12 Million USD | -17.899% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 87.682% |